Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03913559
Title Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications
Therapies
Age Groups: child | adult
Covered Countries USA

Facility Status City State Zip Country Details
Rady Children's Hospital San Diego RECRUITING San Diego California 92123 United States Details
St. Jude Children's Research Hospital RECRUITING Memphis Tennessee 38105 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field